Skip navigation

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Results 1 - 10 of 84 for Gleevec
  1. Gleevec® ... Imatinib is used to treat certain types of leukemia (cancer that begins in the white blood cells) ... other cancers and disorders of the blood cells. Imatinib is also used to treat certain types of ...
  2. ... with tumors that were not treated successfully with imatinib (Gleevec) or people who cannot take imatinib. Sunitinib is also used to treat advanced renal ...
  3. ... whose disease could not be treated successfully with imatinib (Gleevec) or adults who cannot take imatinib because of side effects. Nilotinib is also used ...
  4. ... no longer benefit from other leukemia medications including imatinib (Gleevec) or in those who cannot take these medications ...
  5. ... adults who have previously received other medications, including imatinib (Gleevec). Ripretinib is in a class of medications called ...
  6. ... and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. N Engl J Med. ... Muller-Tidow C, Reiter A, Koschmieder S. Novel imatinib-sensitive PDGFRA-activating point mutations in hypereosinophilic syndrome ...
  7. ... and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. N Engl J Med. ...
  8. ... Schultheis B, Cross NC, Goldman JM. Response to imatinib mesylate in patients with chronic myeloproliferative diseases with ...
  9. Chronic myeloid leukemia is a slow-growing cancer of the blood-forming tissue (bone marrow). Normal bone marrow produces red blood cells (erythrocytes) that carry ...
  10. The ABL1 gene provides instructions for making a protein involved in many processes in cells throughout the body. The ABL1 protein functions as a kinase, ...
previous · 1 · 2 · 3 · 4 · 5 · 6 · 7 · 8 · 9 · next